Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis
PeerJ · 2026
DOI: 10.7717/peerj.20619 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2026. Verfasst von Guodong Zhong und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Fujian Traditional Chinese Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Funds for the innovation of Science and Technology, Fujian Province, Fujian Provincial Natural Science Foundation of China, Fujian Provincial Education and Scientific Research Project.
Abstract (Originalsprache)
Background
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy characterized by significant heterogeneity. We conducted a multi-omics integrated clustering analysis to categorize PDAC molecular subtypes.
Methods
Multi-omics data from The Cancer Genome Atlas-Pancreatic Adenocarcinoma (TCGA-PAAD) were integrated using ten clustering algorithms. Comparisons across PDAC subtypes were performed regarding prognosis, gene mutations, pathways, tumor microenvironment (TME), and chemotherapy sensitivity. A prognostic model was constructed utilizing Cox and Lasso regression based on subtype-related genes.
Results
Samples from the TCGA-PAAD cohort were classified into two subtypes. The CS1 subtype was identified as a high-risk, immunosilent subtype, while the CS2 subtype was characterized as a low-risk, immunoactive subtype. Compared to CS2 subtype, CS1 subtype exhibited shorter survival, higher frequency of genetic mutations, more aggressive tumor-promoting nature, lower TME immune score, and increased sensitivity to chemotherapy. The prognostic model related to PDAC subtypes displayed robust predictive efficiency; IL20RB gene emerged having superior predictive capability.
Conclusions
We successfully identified two distinct PDAC subtypes. The developed prognostic model exhibited strong predictive efficacy; and the upregulation of IL20RB was identified as a promising therapeutic target for PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Fujian Traditional Chinese Medical University, Fuzhou, China.
- The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
- Fujian Medical University Union Hospital, Fuzhou, China.
- Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.
- National Regional Medical Center, Binhai Campus of the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
- Fujian Provincial Hospital, Fuzhou, China.
Förderung
- Joint Funds for the innovation of Science and Technology, Fujian Province
- Fujian Provincial Natural Science Foundation of China
- Fujian Provincial Education and Scientific Research Project
- Scientific Research Project of National Key Clinical Specialty Construction Project
Zitieren
APA
Zhong, G., Wang, L., Fu, P., Xi, B., Li, H., Cheng, Y., Lin, J., & Chen, L. (2026). Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis. PeerJ. https://doi.org/10.7717/peerj.20619
Vancouver
Zhong G, Wang L, Fu P, Xi B, Li H, Cheng Y, et al. Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis. PeerJ. 2026. doi:10.7717/peerj.20619
BibTeX
@article{Zhong2026,
author = {Zhong, Guodong and Wang, Lei and Fu, Peiling and Xi, Beibei and Li, Houqiang and Cheng, Yanhong and Lin, Jianlong and Chen, Linying},
title = {Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis},
journal = {PeerJ},
year = {2026},
doi = {10.7717/peerj.20619}
}
EUVIMED